RESMED INC — Director's Dealing 2013

Nov 15, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-11-13

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-13	ResMed Common Stock	A	2488	—	Acquired	92488	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-13	ResMed Stock Options	$51.25	A	10356	Acquired	2020-11-13	ResMed Common Stock (10356)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	242400	Indirect
ResMed Common Stock	136000	Indirect
ResMed Common Stock	23200	Indirect

Footnotes

F1: Shares awarded are Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2014 or the annual shareholder's meeting in the year following the grant date. Only 50% will distribute upon vesting; the remaining 50% require a holding period until the earlier of the third annual shareholder's meeting following the grant date or 6 months after termination of service.

F2: Options vest in full (i) on the first Nov. 11 following grant date or (ii) the first annual shareholder's meeting following grant date. Options have a required holding period until the earlier of (i) Nov. 11 of the third year following grant date or (ii) six months following termination of directorship.